Top

Published in:

01-02-2009 | Research Articles

Female breast cancer in Gipuzkoa: prognostic factors and survival

Authors: Nerea Larrañaga, Cristina Sarasqueta, Pablo Martínez-Camblor, M. Jesús Mitxelena, Arantza Mendiola, Iñaki Martínez-Pueyo, Mikel Basterretxea

Published in: Clinical and Translational Oncology | Issue 2/2009

Title: Female breast cancer in Gipuzkoa: prognostic factors and survival
Authors: Nerea Larrañaga
Cristina Sarasqueta
Pablo Martínez-Camblor
M. Jesús Mitxelena
Arantza Mendiola
Iñaki Martínez-Pueyo
Mikel Basterretxea
Publication date: 01-02-2009
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 2/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-009-0321-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2009

Sternal resection and reconstruction after malignant tumours

Colorectal cancer prevention

Heterotopic ossification after total hip arthroplasty (THA) in congenital hip disease: comparison of two different prophylactic protocols

Professional burnout among Spanish medical oncologists

Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy

Extravasation of oxaliplatin: an infrequent and irritant toxicity

Keynote webinar | Spotlight on antibody–drug conjugates in cancer